Biomarkers and kits for predicting the risk of developing ad in the elderly and their application
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- HUAZHONG UNIV OF SCI & TECH
- Publication Date
- 2022-05-24
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The present invention relates to the field of medicine, in particular to biomarkers and kits for predicting the risk of AD in the elderly and their applications. Background technique
[0002] Alzheimer's disease (AD) is a primary degenerative disease of the central nervous system and the most common type of dementia. The main clinical symptoms of AD are slow cognitive decline, including progressive loss of memory, logical reasoning ability, and language function, and finally develop into severe dementia.
[0003] At present, there is still a lack of early diagnosis measures for AD, and patients often have irreversible brain damage when they go to the doctor, resulting in poor treatment effect. Therefore, finding early risk factors is of great significance for early diagnosis and intervention.
[0004] Platelets and neurons have many biological similarities, therefore, platelets are ideal materials for finding peripheral biomarkers of central nervous ...